Show simple item record

dc.contributor.authorKorenstein, Deborah
dc.contributor.authorHarris, Russell
dc.contributor.authorElshaug, Adam G
dc.contributor.authorRoss, Joseph S
dc.contributor.authorMorgan, Daniel J
dc.contributor.authorCooper, Richelle J
dc.contributor.authorCho, Hyung J
dc.contributor.authorSegal, Jodi B
dc.date.accessioned2021-02-11T19:07:36Z
dc.date.available2021-02-11T19:07:36Z
dc.date.issued2021-01-21
dc.identifier.urihttp://hdl.handle.net/10713/14670
dc.description.abstractRigorous evidence about the broad range of harms that might be experienced by a patient in the course of testing and treatment is sparse. We aimed to generate recommendations for how researchers might more comprehensively evaluate potential harms of healthcare interventions, to allow clinicians and patients to better include this evidence in clinical decision-making. We propose seven domains of harms of tests and treatments that are relevant to patients: (1) physical impairment, (2) psychological distress, (3) social disruption, (4) disruption in connection to healthcare, (5) labeling, (6) financial impact, and (7) treatment burden. These domains will include a range of severity of harms and variation in timing after testing or treatment, attributable to the service itself or a resulting care cascade. Although some new measures may be needed, diverse data and tools are available to allow the assessment of harms comprehensively across these domains. We encourage researchers to evaluate harms in sub-populations, since the harms experienced may differ importantly by demographics, social determinants, presence of comorbid illness, psychological state, and other characteristics. Regulators, funders, and editors might require either assessment or reporting of harms in each domain or require justification for inclusion and exclusion of different domains. © 2021, Society of General Internal Medicine.en_US
dc.description.urihttps://doi.org/10.1007/s11606-021-06597-9en_US
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofJournal of General Internal Medicineen_US
dc.subject.meshClinical Decision-Makingen_US
dc.subject.meshDiagnostic Techniques and Procedures--adverse effectsen_US
dc.subject.meshPatient Harmen_US
dc.titleTo Expand the Evidence Base About Harms from Tests and Treatmentsen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s11606-021-06597-9
dc.identifier.pmid33479928
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record